BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20695767)

  • 1. Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells.
    Morris MA; McDuffie M; Nadler JL; Ley K
    Autoimmunity; 2011 Mar; 44(2):115-28. PubMed ID: 20695767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs.
    Penaranda C; Tang Q; Ruddle NH; Bluestone JA
    Diabetes; 2010 Jun; 59(6):1461-8. PubMed ID: 20299465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720.
    Maki T; Gottschalk R; Ogawa N; Monaco AP
    Transplantation; 2005 May; 79(9):1051-5. PubMed ID: 15880042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720-induced conversion of conventional Foxp3- CD4+ T cells to Foxp3+ regulatory T cells in NOD mice.
    Sun Y; Wang W; Shan B; Di J; Chen L; Ren L; Li W; Li DJ; Lin Y
    Am J Reprod Immunol; 2011 Nov; 66(5):349-62. PubMed ID: 21623989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of FTY720 on some physiological indexes of Non-Obese Diabetic (NOD) Mice.
    Chen X; Ye S; Zhang S; Li J; Zhu H; Zheng G; Lu Y; Wan H
    Int J Mol Sci; 2012; 13(5):6129-37. PubMed ID: 22754354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
    Xie JH; Nomura N; Koprak SL; Quackenbush EJ; Forrest MJ; Rosen H
    J Immunol; 2003 Apr; 170(7):3662-70. PubMed ID: 12646631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
    Brinkmann V
    Br J Pharmacol; 2009 Nov; 158(5):1173-82. PubMed ID: 19814729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An additional role of FTY720 in chronic colitis].
    Fujii T; Watanabe M
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Feb; 32(1):7-14. PubMed ID: 19252372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
    Yang Z; Chen M; Fialkow LB; Ellett JD; Wu R; Brinkmann V; Nadler JL; Lynch KR
    Clin Immunol; 2003 Apr; 107(1):30-5. PubMed ID: 12738247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720 and central memory: out of sight, out of mind.
    Slavin AJ; Zamvil SS
    Neurology; 2010 Aug; 75(5):388-9. PubMed ID: 20610831
    [No Abstract]   [Full Text] [Related]  

  • 12. FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis.
    Fujii R; Kanai T; Nemoto Y; Makita S; Oshima S; Okamoto R; Tsuchiya K; Totsuka T; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G267-74. PubMed ID: 16574986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.
    Mehling M; Lindberg R; Raulf F; Kuhle J; Hess C; Kappos L; Brinkmann V
    Neurology; 2010 Aug; 75(5):403-10. PubMed ID: 20592255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The S1P-analog FTY720 differentially modulates T-cell homing via HEV: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches.
    Halin C; Scimone ML; Bonasio R; Gauguet JM; Mempel TR; Quackenbush E; Proia RL; Mandala S; von Andrian UH
    Blood; 2005 Aug; 106(4):1314-22. PubMed ID: 15870184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascomycete derivative to MS therapeutic: S1P receptor modulator FTY720.
    Hiestand PC; Rausch M; Meier DP; Foster CA
    Prog Drug Res; 2008; 66():361, 363-81. PubMed ID: 18416311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
    Chiba K
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):92-101. PubMed ID: 19404007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
    Blanc CA; Rosen H; Lane TE
    J Neuroinflammation; 2014 Aug; 11():138. PubMed ID: 25138356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720, a sphingosine 1-phosphate receptor modulator, inhibits CD1d-restricted NKT cells by suppressing cytokine production but not migration.
    Hwang SJ; Kim JH; Kim HY; Kim S; Chung DH
    Lab Invest; 2010 Jan; 90(1):9-19. PubMed ID: 19823172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice.
    Maki T; Gottschalk R; Monaco AP
    Transplantation; 2002 Dec; 74(12):1684-6. PubMed ID: 12499880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.
    Ntranos A; Hall O; Robinson DP; Grishkan IV; Schott JT; Tosi DM; Klein SL; Calabresi PA; Gocke AR
    J Neuroimmunol; 2014 May; 270(1-2):13-21. PubMed ID: 24680062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.